Mayne Pharma
Claire Smith is a seasoned professional in the field of quality control and laboratory science, currently serving as the Quality Control Team Leader at Mayne Pharma since April 2018, overseeing a diverse QC team across multiple product streams. Previously, Claire held roles as Quality Control Coordinator and Quality Control Chemist at Mayne Pharma, where responsibilities included coordinating stability and microbiology efforts and conducting analytical chemistry and process validation. Prior experience includes serving as a Medical Laboratory Scientist at SA Pathology, specializing in surgical pathology and immunohistochemistry, as well as working as a Forensic Scientist at Forensic Science S.A. Academic contributions include positions as an Academic Tutor and recipient of a Summer Research Scholarship at the University of Adelaide. Claire holds a Bachelor of Health Sciences with Honors from the University of Adelaide and a Master of Education in Higher Education from the University of South Australia.
Mayne Pharma
1 followers
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.